Pacira BioSciences (PCRX) Amortizatization of Intangibles (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Amortizatization of Intangibles of $570000.0 for Q1 2026, down 70.16% year-over-year from $1.9 million in Q1 2025, and down 88.19% quarter-over-quarter from $4.8 million in Q4 2025.
Pacira BioSciences (PCRX) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Pacira BioSciences' Amortizatization of Intangibles history runs 17 years deep, the most recent figure standing at $570000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 70.16% year-over-year to $570000.0; the TTM figure through Mar 2026 stood at $5.5 million (down 41.17% YoY), while the FY2025 annual figure was $4.9 million, down 33.61% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $570000.0, down from $4.8 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $7.4 million in Q4 2024, with the low at $23000.0 in Q2 2024.
- The 5-year median for Amortizatization of Intangibles is $675000.0 (2023), against an average of $1.3 million.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles sank 96.44% in 2024, then soared 7858.33% in 2025.
- Pacira BioSciences' Amortizatization of Intangibles stood at $700000.0 in 2022, then jumped by 449.71% to $3.8 million in 2023, then jumped by 91.03% to $7.4 million in 2024, then plunged by 34.35% to $4.8 million in 2025, then tumbled by 88.19% to $570000.0 in 2026.
- Business Quant data shows PCRX's Amortizatization of Intangibles at $570000.0 in Q1 2026, $4.8 million in Q4 2025, and $56000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Pacira BioSciences | 970.37 Mn | 719.34 Mn | 148.24 Mn | 357,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 357,000.00 |
| Jun 30, 2026 | 357,000.00 |
| Mar 31, 2026 | 570,000.00 |
| Mar 31, 2026 | 570,000.00 |
| Dec 31, 2025 | 4.83 Mn |
| Dec 31, 2025 | 4.83 Mn |
| Sep 30, 2025 | 56,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Mar 31, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | 7.35 Mn |
| Dec 31, 2024 | 7.35 Mn |
| Sep 30, 2024 | 23,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Mar 31, 2024 | 24,000.00 |